Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
TriPath Imaging signs multi-year agreement for liquid-based Pap test
May 13th, 2004
TriPath Imaging, Inc., (TPTH) announced a new multi-year agreement with Henry Ford Health System, under which Henry Ford Health System will use TriPath Imaging's SurePath liquid-based Pap test for cervical cancer screening, replacing the use of conventional Pap tests. "Henry Ford is committed to providing exceptional quality and cost- effective care to our patients through the use of enhanced products and technology solutions," said John T. Waugh, Henry Ford's director of laboratory operations, pathology, and lab medicine. "After an extensive review of all options, we plan to convert fully to TriPath Imaging's proprietary liquid-based Pap...
Source: Women's Health Weekly (2004-05-13)
|
